Zabdeno

Zabdeno is an adenovirus-based vaccine designed to help protect against Ebola Zaire virus. It contains a viral vector carrying a gene for the Ebola Zaire envelope glycoprotein. This vaccine is administered via intramuscular injection and is used in specific immunization schedules.

Zabdeno is used for active immunization to help prevent disease caused by the Ebola Zaire virus. It is intended for individuals at risk of exposure, such as healthcare workers or those in outbreak areas. The vaccine works by prompting the immune system to produce antibodies against the virus. It is part of a two-dose vaccination regimen.

After vaccination with Zabdeno, the immune system recognizes the Ebola Zaire glycoprotein and begins producing antibodies. This process may lead to mild symptoms like injection site pain or fatigue. Most individuals tolerate the vaccine well, though some may experience temporary discomfort.

Zabdeno should be handled and administered by trained healthcare professionals. It is important to store the vaccine at the recommended temperature to maintain its effectiveness. Individuals with severe allergies to any component of the vaccine should avoid its use. A medical history review is recommended before vaccination.

Limited data exists on interactions with other vaccines or medications. However, Zabdeno should not be administered simultaneously with live vaccines unless medically advised. Immunosuppressive therapies may reduce the vaccine's effectiveness. Always inform your healthcare provider about any medications or treatments you are receiving.